Status:
UNKNOWN
Smartphone Message to Improve the Drug Compliance in Pregnant Women.
Lead Sponsor:
The University of Hong Kong
Conditions:
Pregnancy Related
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
As technology advances, smartphones are now widely available and can provide a convenient and effective means to improve drug compliance by sending an electronic reminder on a regular basis. In a meta...
Eligibility Criteria
Inclusion
- All women age ≥ 18 years old
- Able to receive electronic reminder through smartphohne
- Gestational age less than 16 completed weeks as defined by pelvic ultrasound
- Part 1: Need to take aspirin or progesterone for prevention of pre-eclampsia or preterm birth respectively
- Part 2: Given multivitamin as health supplementation
Exclusion
- For Part 1:
- History of adverse reaction to aspirin
- History of adverse reaction to progesterone
- History of breast or genital tract malignancy
- History of suspected thromboembolic disease
- Congenital uterine anomaly
- Unwillingness or inability to comply with study procedures
- Known paternal or maternal abnormal karyotype
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2024
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT04295265
Start Date
March 1 2020
End Date
February 28 2024
Last Update
March 4 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.